Cost-effectiveness of needle and syringe exchange for the prevention of HIV in New York City

Journal of HIV/AIDS and Social Services

Volumn 7, Issue 3, 2008, Pages 229-240

  Belani, Hrishikesh K ^a,c   Muennig, Peter A ^b  

^a Lower East Side Harm Reduction Center   (United States)

^b Columbia University ^*  (United States)

^c NONE   (United States)

Author keywords

Cost effectiveness analysis; Harm reduction; HIV Prevention; Needle and syringe exchange; Needle exchange; NEP; NSE; NSP; SEP; Syringe exchange

Indexed keywords

DECISION ANALYSIS; DISEASE CONTROL; DISEASE PREVALENCE; DISEASE TRANSMISSION; DRUG USER; HUMAN IMMUNODEFICIENCY VIRUS; NUMERICAL MODEL; RISK ASSESSMENT; STRATEGIC APPROACH;

NEW YORK [NEW YORK (STT)]; NEW YORK [UNITED STATES]; NORTH AMERICA; UNITED STATES;

EID: 65749124242     PISSN: 15381501     EISSN: 1538151X     Source Type: Journal    
DOI: 10.1080/15381500802307492     Document Type: Article

References (15)

1. Jarlais, D. C. Des, Marmor, M., Paone, D., Titus, S., Shi, Q. Perlis, T. et al. (1996) HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet, 348:9033, pp. 987-991.
2. Jarlais, D. C. Des, Perlis, T., Arasteh, K., Torian, L. V., Beatrice, S. Milliken, J. et al. (2005) HIV incidence among injection drug users in New York City, 1990 to 2002: Use of serologic test algorithm to assess expansion of HIV prevention services. American Journal of Public Health, 95:8, pp. 1439-1444.
3. Gold, M., Gafni, A., Nelligan, P. and Millson, P. (1997) Needle exchange programs: An economic evaluation of a local experience. Canadian Medical Association Journal, 157:3, pp. 255-262.
4. (1995) Preventing HIV transmission: The role of sterile needles and bleach, National Academy Press/Institute of Medicine, Washington, DC
5. (2006)
6. Hurley, S. F., Jolley, D. J. and Kaldor, J. M. (1997) Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet, 349:9068, pp. 1797-1800.
7. Kaplan, E. H. and O'keefe, E. (1993) Let the needles do the talking! Evaluating the New Haven needle exchange. Interfaces, 23, pp. 7-26.
8. Laufer, F. N. (2001) Cost-effectiveness of syringe exchange as an HIV prevention strategy. Journal of Acquired Immune Deficiency Syndrome, 28:3, pp. 273-278.
9. (2004) HIV prevalence in New York City, 2002: HIV epidemiology program special supplemental report
10. (2006)
11. (2006) HIV Epidemiology program quarterly report
12. (2001) AIDS in New York State
13. Paltiel, A. D., Weinstein, M. C., Kimmel, A. D., Seage 3rd, G. R., Losina, E. Zhang, H. et al. (2005) Expanded screening for HIV in the United States-An analysis of cost-effectiveness. New England Journal of Medicine, 352:6, pp. 586-595.
14. Weinstein, M. C., Siegel, J. E., Gold, M. R., Kamlet, M. S. and Russell, L. B. (1996) Recommendations of the panel on cost-effectiveness in health and medicine. Journal of the American Medical Association, 276:15, pp. 1253-1258.
15. Wynn, G. H., Zapor, M. J., Smith, B. H., Wortmann, G., Oesterheld, J. R. Armstrong, S. C. et al. (2004) Antiretrovirals, part 1: Overview, history, and focus on protease inhibitors. Psychosomatics, 45:3, pp. 262-270.